Soft tissue tumours of the retroperitoneum

Sarcoma

Volumn 4, Issue 1-2, 2000, Pages 17-26

  Graadt Van Roggen, J Frans ^b   Hogendoorn, Pancras C W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

Retroperitoneum; Review; Sarcoma; Soft tissue tumour

Indexed keywords

ARTICLE; CANCER CYTODIAGNOSIS; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; LIPOMA; LIPOSARCOMA; MESENCHYME; NEEDLE BIOPSY; NEURILEMOMA; PREVALENCE; PRIORITY JOURNAL; RETROPERITONEAL TUMOR; RHABDOMYOSARCOMA; SOFT TISSUE TUMOR;

EID: 0033942407     PISSN: 1357714X     EISSN: None     Source Type: Journal    
DOI: 10.1155/s1357714x00000049     Document Type: Article

References (82)

1. 1 Enzinger FM, Weiss SW. Soft tissue tumors, 3rd edn. St Louis, MO: C.V. Mosby; 1995.
2. 2 Rosai J. Ackerman's surgical pathology, 8th edn. St. Louis, MO: Mosby; 1996.
3. 3 Crist WM, Kun LE. Common solid tumors of childhood. N Engl J Med 1991; 324:461-71.
4. 4 Graadt van Roggen JF, Bovee JVMG, Morreau J, Hogendoorn PCW. Diagnostic and prognostic implications of the unfolding molecular biology of bone and soft tissue tumours. J Clin Pathol 1999; 52:481-9.
5. 5 Bloem JL, Van der Woude HJ, Hogendoorn PCW, Deutsch AL, Mink JH, editors. Bone tumors, 2nd edn. Philadelphia: Lippincott-Raven Publishers; 1996; 11, MRI of the musculoskeletal system: a teaching file, pp. 655-719.
6. 6 Verstraete KL, Van der Woude HJ, Hogendoorn PCW, de Deene Y, Kunnen M, Bloem JL. Dynamic contrast-enhanced MR imaging of musculoskeletal tumors: basic principles and clinical applications. JMRI 1996; 6:311-21.
7. 7 Van der Woude HJ, Verstraete KL, Hogendoorn PCW, Taminiau AHM, Bloem JL. Fast dynamic contrast-enhanced substraction MR imaging in patients with musculoskeletal tumors.
8. 8 Lucas JD, O'Doherty MJ, Cronin BF, et al. Prospective evaluation of soft tissue masses and sarcomas using fluorodeoxyglucose positron emission tomography. Br J Surg 1999; 86:550-6.
9. 9 Lucas JD, O'Doherty MJ, Wong JC, et al. Evaluation of fluorodeoxyglucose positron emission tomography in the management of soft-tissue sarcomas. J Bone Joint Surg [Br] 1998; 80:441-7.
10. 10 Jones J, Ross E, Matz L, Edwards D, Davies D. Retroperitoneal fibrosis. Am J Med 1970; 48:203-8.
11. 11 Osborne CA, Butler J, Bloustein P, Sumner G. Idiopathic retroperitoneal fibrosis (sclerosing retroperitonitis). Hum Pathol 1987; 18:735-9.
12. 12 Weiss SW. Proliferative fibroblastic lesions. From hyperplasia to neoplasia. Am J Surg Pathol 1986; 10(suppl 1):14-25.
13. 13 Haggitt RC, Reid BJ. Hereditary gastrointestinal polyposis syndromes. Am J Surg Pathol 1986; 10:871-87.
14. 14 Parsons M, Harris S, Longstaff A, Grainger R. Xanthogranulomatous pyelonephritis. A pathological, clinical and aetiological analysis of 87 cases. Diagn Histopathol 1983; 6:203-19.
15. 15 Tomera K, Farrow G, Lieber M. Sarcomatoid renal carcinoma. J Urol 1983; 130:657-9.
16. 16 Gonzalez-Crussl F. Retroperitoneal teratoma. Pediatr Pathol 1990; 10:1-36.
17. 17 Lack EE, Travis W, Welch K. Retroperitoneal germ cell tumors in childhood. A clinical and pathological study of 11 cases. Cancer 1985; 56:602-8.
18. 18 Graadt van Roggen JF, Welvaart K, de Roos A, Offerhaus GJA, Hogendoorn PCW. Adenocarcinoma arising within a tailgut cyst: clinicopathological description and follow-up of an unusual case. J Clin Pathol 1999; 52:310-2.
19. 19 Meis JM, Enzinger FM. Myolipoma of soft tissue. Am J Surg Pathol 1991; 15:121-5.
20. 20 Allen PW. Tumors and proliferations of adipose tissue: a clinicopathologic approach. New York: Masson Publishing, 1981.
21. 21 Weiss SW. Lipomatous Tumours. Monogr Pathol 1996; 38:207-39.
22. 22 Mentzel T, Fletcher CDM. Lipomatous tumours of soft tissues: an update. Virchows Arch [A] 1995; 427:353-63.
23. 23 DeiTos AP. Adipocytic tumors: new entities and evolving concepts. Rev Esp Pathol 1999; 32:271-3.
24. 24 Lucas J, Nascimento AG, Sanjay KSS, Rock MG. Well-differentiated liposarcoma: the Mayo Clinic experience with 58 cases. Am J Clin Pathol 1994; 102:677-83.
25. 25 Elgar F, Goldblum JR. Well-differentiated liposarcoma of the retroperitoneum: a clinicopathologic analysis of 25 cases, with particular attention to the extent of low-grade dedifferentiation. Mod Pathol 1997; 10:113-20.
26. 26 Fletcher JA, Enzinger FM, Weiss SW, editors. Soft tissue tumors, 3rd edn. St. Louis, MO: Mosby; 1995; 5, Cytogenetic analysis of soft tissue tumors, pp. 105-18.
27. 27 Fletcher CD, Akerman M, Dal Cin P, et al. Correlation between clinicopathological features and karyotype in lipomatous tumors. A report of 178 cases from the CHAMP study group. Am J Pathol 1996; 148:623-30.
28. 28 Mentzel T, Fletcher CD. Dedifferentiated myxoid liposarcoma: a clinicopathologic study suggesting a closer relationship between myxoid and well-differentiated liposarcoma. Histopathol 1997; 30:457-63.
29. 29 Hashimoto H, Enjoji M. Liposarcoma. A clinicopathologic subtyping of 52 cases. Acta Pathol Jpn 1982; 32:933-48.
30. 30 Weiss SW, Weiss SW, Brooks JSJ, editors. Soft tissue tumors. Augusta: Williams and Wilkins; 1996; 7, Lipomatous tumors, pp. 207-39.
31. 31 Henricks WH, ChuY-C, Goldblum JR, Weiss SW. Dedifferentiated liposarcoma: a clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation. Am J Surg Pathol 1997; 21:271-81.
32. 32 Weiss SW, Rao VK. Well differentiated liposarcoma (atypical lipoma) of deep soft tissue of the extremeties, retroperitoneum, and miscellaneous sites: a follow up study of 92 cases with analysis of the incidence of "dedifferentiation". Am J Surg Pathol 1992; 16:1051-68.
33. 33 Kilpatrick SE, Doyon J, Choong PFM, Sim FH, Nascimento AG. The clinicopathologic spectrum of myxoid and round cell liposarcoma. A study of 95 cases. Cancer 1996; 77:1450-8.
34. 34 Weiss SW, Rao VK. Well-differentiated liposarcoma (atypical lipoma) of deep soft tissues of the extremeties, retroperitoneum, and miscellaneous sites. A follow-up study of 92 cases with analysis of the incidence of "dedifferentiation". Am J Surg Pathol 1992; 16:1051-8.
35. 35 Smith TA, Easley KA, Goldblum JR. Myxoid/round cell liposarcoma of the extremeties. A clinicopathologic study of 29 cases with particular attention to extent of round cell liposarcoma. Am J Surg Pathol 1996; 20:171-80.
36. 36 Fletcher CDM. Will we ever reliably predict prognosis in a patient with myxoid and round cell liposarcoma? Adv Anat Pathol 1997; 4:108-13.
37. 37 Abe S, Imamura T, Park P, et al. Small round-cell type of malignant peripheral nerve sheath tumor. Mod Pathol 1998; 11:747-53.
38. 38 Erlandson RA, Klimstra DS, Woodruff JM. Subclassification of gastrointestinal stromal tumors based on evaluation by electron microscopy and immunohistochemistry. Ultrastruct Pathol 1996; 20:373-93.
39. 39 Chan JKC. Mesenchymal tumors of the gastrointestinal tract: a paradise for acronyms (STUMP, GIST, GANT, and now GIPACT), Implications of c-kit in genesis, and yet another of many emerging roles of the interstitial cell of Cajal in the pathogenesis of gastrointestinal disease. Adv Anat Pathol 1999; 6:19-40.
40. 40 Royani B, Smith TA, Reith JD, Goldblum JR. Retroperitoneal leiomyosarcomas unassociated with the gastrointestinal tract: a clinicopathologic analysis of 117 cases. Mod Pathol 1999; 12:21-8.
41. 41 Sreekantaiah C, Davis JR, Sandberg AA. Chromosomal abnormalities in leiomyosarcomas. Am J Surg Pathol 1993; 142:293-305.
42. 42 Kodet R, Newton WA, Jr, Hamoudi AB, Asmar L, Jacobs DL, Maurer HM. Childhood rhabdomyosarcoma with anaplastic (pleomorphic) features. A report of the intergroup rhabdomyosarcoma study. Am J Surg Pathol 1993; 17:443-553.
43. 43 Huang CJ. Rhabdomyosarcoma involving the genitourinary organs, retroperitoneum and pelvis. J Pediatr Surg 1986; 21:101-7.
44. 44 Kelly KM, Womer RB, Sorensen PHB, Xiong Q, Barr FG. Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma. J Clin Oncol 1997; 15:1831-6.
45. 45 Barr FG, Galli N, Hollick J, Biegel JA, Rovera G, Emanuel B.S. Rearrangement of the PAX3 paired box in the pediatric solid tumor alveolar rhabdomyosarcoma. Nature Gen 1993; 3:113-7.
46. 46 Davis RJ, D'Cruz CM, Lovell MA, Biegel JA, Barr FG. Fusion of PAX7 to FKHR by the variant t(1; 13)(p36; q14) translocation in alveolar rhabdomyosarcoma. Cancer Res 1994; 54:2869-72.
47. 47 Regan JF, Juler GL, Schmutzer KJ. Retroperitoneal neurilemoma. Am J Surg 1977; 134:140-5.
48. 48 White W, Shiu M, Rosenblum M, Erlandson R, Woodruff J. Cellular schwannoma: a clinicopathologic study of 57 patients and 58 tumors. Cancer 1990; 66:1266-75.
49. 49 Casadei G, Scheithauer B, Hirose T, Manfrini M, van Houten C, Wood M. Cellular schwannoma: a clinicopathologic, DNA flow cytometric, and proliferation marker study of 70 patients. Cancer 1995; 75:1109-19.
50. 50 Lodding P, Kindblom L, Angervall L, Stenman G. Cellular schwannoma. A clinicopathologic study of 29 cases. Virchows Arch [A] 1990; 416:237-48.
51. 51 Woodruff JM. The pathology and treatment of peripheral nerve tumors and tumor-like conditions. A Cancer J Clin 1993; 43:290-308.
52. 52 Ducatman BS, Scheithauer BW, Piepgras DG, Reiman HM, Ilstrup DM. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer 1986; 57:2006-21.
53. 53 Brooks JSJ, Freeman M, Enterline HT. Malignant triton tumors. Natural history and immunohistochemistry of nine new cases with literature review. Cancer 1985; 55:2543-9.
54. 54 Fletcher CDM. Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma. Am J Surg Pathol 1992; 16:213-28.
55. 55 Ordóñez NG. Desmoplastic small round cell tumor. Am J Surg Pathol 1998; 22:1303-13.
56. 56 Gerald WL, Rosai J, Ladanyi M. Characterisation of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumor. Proc Natl Acad Sci USA 1995; 92:1028-32.
57. 57 Kubben FJGM, Kroon FP, Hogendoorn PCW, et al. Absence of Epstein-Barr virus in a gastrointestinal stromal cell tumour (GIST) in an adult Human Immunodeficiency Virus-seropositive patient with past Epstein-Barr virus (EBV) infection. Eur J Gastroent Hepatol 1997; 9:721-4.
58. 58 Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations in c-kit in human gastrointestinal stromal tumors. Science 1998; 279:577-80.
59. 59 Tsang WYW, Chan JKC. Kaposi-like infantile hemangioendothelioma. A distinctive vascular tumor of the retroperitoneum. Am J Surg Pathol 1991; 15:982-9.
60. 60 Vallat-Decouvelaere A, Dry S, Fletcher CDM. Atypical and malignant solitary fibrous tumors in extrathoracic locations. Evidence of their comparability to intrathoracic tumors. Am J Surg Pathol 1998; 22:1501-11.
61. 61 Luttges J, Mentzel T, Hubner G, Kloppel G. Solitary-fibrous tumor of the pancreas: a new member of the small group of mesenchymal pancreatic tumours. Virchows Arch [B] 1999; 435:37-42.
62. 62 Fletcher CDM. Haemangiopericytoma - a dying breed? Reappraisal of an 'entity' and its variants: a hypothesis. Curr Diagn Pathol 1994; 1:19-23.
63. 63 Nappi O, Ritter JH, Pettinato G,Wick MR. Hemangiopericytoma: histopathological pattern or clinicopathologic entity? Semin Diagn Pathol 1995; 12:221-32.
64. 64 Lack EE, Cubilla AL, Woodruff JM, Lieberman PH. Extra-adrenal paragangliomas of the retroperitoneum: a clinicopathologic study of 12 tumors. Am J Surg Pathol 1980; 4:109-20.
65. 65 Moran CA, Albores-Saavedra J, Wenig BM, Mena H. Pigmented extraadrenal paragangliomas. A clinicopathologic and immunohistochemical study of five cases. Cancer 1997; 79:398-402.
66. 66 Kransdorf MJ. Benign soft-tissue tumors in a large referral population: distribution of specific diagnoses by age, sex, and location. Am J Roentgenol 1995; 164:395-402.
67. 67 Meis JM, Enzinger FM. Inflammatory fibrosarcoma of the mesentery and retroperitoneum. A tumor closely simulating inflammatory pseudotumor. Am J Surg Pathol 1991; 15:1146-56.
68. 68 Shmookler BM. Retroperitoneal synovial sarcoma. A report of four cases. Am J Clin Pathol 1982; 77:686-91.
69. 69 Miracco C, Laurini L, Santopietro R, et al. Intimal-type primary sarcoma of the aorta. Report of a case with evidence of rhabdomyoblastic differentiation. Virchows Arch [B] 1999; 435:62-6.
70. 70 Newman PL, Fletcher CDM. Malignant mesenchymoma. Clinicopathologic analysis of a series with evidence of low-grade behaviour. Am J Surg Pathol 1991; 15:607-14.
71. 71 Gurarangan S, Bowman LC, Parham DM, et al. Primary extrarenal rhabdoid tumors. Clinicopathologic features and response to ifosfamide. Cancer 1993; 71:2653-9.
72. 72 Shimada H, Newton WA, Jr, Soule EH, Qualman SJ, Aoyama C, Maurer HM. Pathologic features of extra-osseous Ewing's sarcoma: a report from the intergroup rhabdomyosarcoma study. Hum Pathol 1988; 19:442-53.
73. 73 Bane B, Evans HL, Ro JY, et al. Extraskeletal osteosarcoma. A clinicopathologic review of 26 cases. Cancer 1990; 65:2762-70.
74. 74 van Rijswijk CSP, Hogendoorn PCW, Tjong A Lieng JGS, Kroon HM. Retroperitoneal extraskelatal osteosarcoma. J Clin Pathol 2000.
75. 75 Akerman M, Willen H. Critical review on the role of fine needle aspiration in soft tissue tumors. Pathol Case Rev 1998; 3:111-7.
76. 76 Coindre JM, Trojani M, Contesso G, et al. Reproducibility of a histopathologic grading system for adult soft tissue sarcoma. Cancer 1986; 58:306-9.
77. 77 Costa J, Wesley RA, Glatstein E, Rosenberg SA. The grading of soft tissue sarcomas. Results of a clinicohistopathologic correlation in a series of 163 cases. Cancer 1984; 53:530-41.
78. 78 Meis-Kindblom JM. On the comparison of apples, oranges and sundry fruits: problems with grading and prognostication in soft tissue tumors. Rev Esp Pathol 1999; 32:426-7.
79. 79 Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop 1980; 153:106-20.
80. 80 Enneking WF. Musculoskeletal tumor staging: 1988 update. Cancer Treat Res 1989; 44:39-49.
81. 81 Enneking WF, Enneking WF, editors. Clinical musculoskeletal pathology, 3rd edn. Gainesville, Florida: University Presses of Florida; 1990; Appendix A. The staging system for benign and malignant tumors of the musculoskeletal system, pp. 451-66.
82. 82 Fletcher CDM, Kempson RL, Weiss SW. Recommendations for the reporting of soft tissue sarcoma. Virchows Arch [B] 1999; 434:187-91.